GB0502542D0 - Method - Google Patents
MethodInfo
- Publication number
- GB0502542D0 GB0502542D0 GB0502542A GB0502542A GB0502542D0 GB 0502542 D0 GB0502542 D0 GB 0502542D0 GB 0502542 A GB0502542 A GB 0502542A GB 0502542 A GB0502542 A GB 0502542A GB 0502542 D0 GB0502542 D0 GB 0502542D0
- Authority
- GB
- United Kingdom
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0502542A GB0502542D0 (en) | 2005-02-08 | 2005-02-08 | Method |
| EP05818307A EP1844054A2 (en) | 2004-12-17 | 2005-12-14 | Thiazolopyrimidine compounds for the modulation of chemokine receptor activity |
| US11/721,583 US20090239882A1 (en) | 2004-12-17 | 2005-12-14 | Thiazolopyramidine Compounds for the Modulation of Chemokine Receptor Activity |
| PCT/GB2005/004825 WO2006064228A2 (en) | 2004-12-17 | 2005-12-14 | Thiazolopyramidine compounds for the modulation of chemokine receptor activity |
| JP2007546178A JP2008524186A (en) | 2004-12-17 | 2005-12-14 | Thiazolopyramidine compounds for modulation of chemokine receptor activity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0502542A GB0502542D0 (en) | 2005-02-08 | 2005-02-08 | Method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0502542D0 true GB0502542D0 (en) | 2005-03-16 |
Family
ID=34355936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0502542A Ceased GB0502542D0 (en) | 2004-12-17 | 2005-02-08 | Method |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB0502542D0 (en) |
-
2005
- 2005-02-08 GB GB0502542A patent/GB0502542D0/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0504774D0 (en) | Method | |
| EP1864785A4 (en) | Seterolithography method | |
| GB0503836D0 (en) | Method | |
| GB0512214D0 (en) | Method | |
| GB0519303D0 (en) | Chemo-immunotherapy method | |
| GB0520375D0 (en) | Method | |
| GB0504096D0 (en) | Method | |
| GB0509433D0 (en) | Method | |
| GB0504184D0 (en) | Method | |
| GB0507123D0 (en) | Method | |
| GB0520235D0 (en) | Method | |
| GB0510536D0 (en) | Method | |
| GB0502046D0 (en) | Method | |
| GB0515695D0 (en) | Method | |
| GB0508420D0 (en) | Method | |
| GB0505756D0 (en) | Method | |
| GB0509305D0 (en) | Method | |
| GB0509437D0 (en) | Method | |
| GB0520981D0 (en) | Method | |
| GB0518667D0 (en) | Method | |
| GB0504182D0 (en) | Method | |
| GB0506670D0 (en) | Method | |
| GB0509956D0 (en) | Method | |
| GB0502360D0 (en) | Method | |
| GB0508493D0 (en) | Method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |